Results 211 to 220 of about 486,388 (376)
The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli +7 more
wiley +1 more source
Targeting p38α in cancer: challenges, opportunities, and emerging strategies
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley +1 more source
IN VITRO ESTABLISHMENT OF Eucalyptus globulus HYBRID CLONES
http://dx.doi.org/10.5902/198050986626O presente estudo teve como objetivos avaliar o comportamento de clones de Eucalyptus grandis W.Hill ex Maiden x Eucalyptus globulus Labill e Eucalyptus urophylla S.T.Blake x Eucalyptus globulus Labill e o efeito de diferentes introduções in vitro (aos 30, 90 e 150 dias após a poda do ápice das minicepas) na fase ...
Borges, Silvano Rodrigues +6 more
openaire +1 more source
Growth regulator and axillary bud position effects on in vitro establishment of Vitis rotundifolia
Sudarsono, R. Goldy
semanticscholar +1 more source
Correlation of the differential expression of PIK3R1 and its spliced variant, p55α, in pan‐cancer
PIK3R1 undergoes alternative splicing to generate the isoforms, p85α and p55α. By combining large patient datasets with laboratory experiments, we show that PIK3R1 spliced variants shape cancer behavior. While tumors lose the protective p85α isoform, p55α is overexpressed, changes linked to poorer survival and more pronounced in African American ...
Ishita Gupta +10 more
wiley +1 more source
Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon +4 more
wiley +1 more source
Cancer therapy-related cardiovascular aging: mechanisms, monitoring, and intervention strategies. [PDF]
Lin X, Wu Z, Liu Y, Liao X.
europepmc +1 more source
In vitro establishment from mature nodal segments of Persian Lime (Citrus latifolia Tan.) [PDF]
Humberto Estrella‐Maldonado +5 more
openalex +1 more source

